|
The document reports on a study conducted by Riker Laboratories, a subsidiary of 3M, which found that cholestyramine treatment significantly enhanced the elimination of carbon-14 labeled FC-95 and FC-143 in male rats, reducing retention in liver, plasma, and red blood cells while increasing fecal excretion.
|
1930 |
AR226-0459
|
pBdB7ayjRQaEzXxNXEm3bj5qB |
29 |